Surgical Innovations Unit, Westmead Hospital, Cnr Hawkesbury and Darcy Road, Westmead, NSW, 2145, Australia.
Department of Surgery, Westmead Hospital, Sydney, Australia.
World J Surg. 2023 Jun;47(6):1486-1492. doi: 10.1007/s00268-023-06941-6. Epub 2023 Feb 22.
Skin abscesses are a common emergency presentation often requiring incision and drainage; however, issues with theatre access lead to delays in management and high costs. The long-term impact in a tertiary centre of a standardised day-only protocol is unknown. The aim was to evaluate the impact of day-only skin abscess protocol (DOSAP) for emergency surgery of skin abscesses in a tertiary institution in Australia and to provide a blueprint for other institutions.
A retrospective cohort study analysed several time periods: Period A (July 2014 to 2015, n = 201) pre-DOSAP implementation, Period B (July 2016 to 2017, n = 259) post-DOSAP, and Period C (July 2018 to 2022, n = 1,625) prospectively analysed four 12-month periods to assess long-term utilisation of DOSAP. Primary outcomes were length of stay and delay to theatre. Secondary outcome measures included theatre start time, representation rates and total costs. Statistical analysis using nonparametric methods was used to analyse the data.
There was a significant decrease in ward length of stay (1.25 days vs. 0.65 days, P < 0.0001), delay to theatre (0.81 days vs. 0.44 days, P < 0.0001) and theatre start time before 10AM (44 cases vs. 96 cases, P < 0.0001) after implementation of DOSAP. There was a significant decrease in median cost of admission of $711.74 after accounting for inflation. Period C reported 1,006 abscess presentations successfully managed by DOSAP over the four-year period.
Our study demonstrates the successful implementation of DOSAP in an Australian tertiary centre. The ongoing utilisation of the protocol demonstrates the ease of applicability.
皮肤脓肿是一种常见的急症,常需切开引流;然而,手术室资源不足导致治疗延误和成本增加。在澳大利亚的一家三级医院,标准化日间手术方案(DOSAP)对皮肤脓肿急诊手术的长期影响尚不清楚。本研究旨在评估该方案在澳大利亚一家三级医院的应用效果,并为其他医院提供参考。
回顾性队列研究分析了多个时间段:DOSAP 实施前的 A 期(2014 年 7 月至 2015 年,n=201)、DOSAP 实施后的 B 期(2016 年 7 月至 2017 年,n=259)和前瞻性分析的 C 期(2018 年 7 月至 2022 年,n=1625)4 个 12 个月的时间段,以评估 DOSAP 的长期应用效果。主要结局指标为住院时间和手术延迟。次要结局指标包括手术开始时间、就诊率和总费用。采用非参数方法进行数据分析。
DOSAP 实施后,住院时间(1.25 天 vs. 0.65 天,P<0.0001)、手术延迟(0.81 天 vs. 0.44 天,P<0.0001)和 10 点前开始手术的比例(44 例 vs. 96 例,P<0.0001)显著降低。考虑通胀因素后,住院费用中位数降低了 711.74 美元。C 期在四年间成功管理了 1006 例皮肤脓肿。
本研究表明,DOSAP 在澳大利亚的一家三级医院得到了成功实施。该方案的持续应用证明了其易于实施。